Treatment outcomes and costs of a simplified antiretroviral treatment strategy for hepatitis C among Hepatitis C Virus and Human Immuno deficiency Virus co-infected patients in Ukraine.
Sergie AntoniakCharles S ChaselaMorgan Julie FreimanYulia StopolianskaTetiana BarnardMalini M GandhiMariia LiulchukZhanna TsenilovaTretiakov ViktorJeri DibleConstance N Wose KingeFrancis AkpanThomas MiniorNtombi SigwebelaSofiane MohamedMatthiue BarralonFadzai MarangeClint CavenaughCharles Vander HorstSvitlana AntonyakThembisile XuluKara W ChewIan M SanneSydney Rosennull nullPublished in: JGH open : an open access journal of gastroenterology and hepatology (2022)
A standard dose of LDV and SOF, with ribavirin as per protocol, resulted in good outcomes for patients with both hepatitis C alone and co-infected with hepatitis C/HIV. Program costs in Ukraine were modest using generic medication.
Keyphrases
- hepatitis c virus
- human immunodeficiency virus
- hiv infected
- hiv positive
- antiretroviral therapy
- hiv aids
- endothelial cells
- randomized controlled trial
- quality improvement
- hiv testing
- healthcare
- men who have sex with men
- replacement therapy
- induced pluripotent stem cells
- adipose tissue
- south africa
- pluripotent stem cells